Access
This article is part of Nature's premium content.
Published online 17 October 2007 | Nature | doi:10.1038/news.2007.174
News
Malaria vaccine hope for Africa's babies
Mozambique trial shows vaccine safe for young infants.
A malaria vaccine trial in Mozambique has shown that the treatment is safe and effective for babies aged just a few weeks. The research brings the vaccine a step closer to widespread use; good news particularly for young infants, who are most at risk of being killed by the disease.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email redesign@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.
It is absolutely delightful to read about the promising prospects of the RTS,S, vaccine for the control of Plasmodium falciparum malaria. As a Biomedical Lab Scientist in Medical Microbiology/Parasitology for the past 18years in primary to tertiary healthcare services in Nigeria, I have observed deadly infections in neonates, children and pregnant women. Please the trials should be extended to the coastal cities of Nigeria like Calabar in Cross River State and Lagos, where malaria is hyperendemic and the illness spikes in the raining season. Congratulations to all involved in this discovery!. EDET E. ANWAN (BSc, MSc, AMLSCN) Email:edetanwan@yahoo.com UCTH CALABAR, NIGERIA.